Physician profile
Robert Dorsey
NPI 1013905520
$3,375.03
in general payments reported to CMS, 2019-2025
14 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $419 · 2021: $274 · 2022: $309 · 2023: $542 · 2024: $1,310 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,827 · Travel and Lodging: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,827.47 |
| Travel and Lodging | $546.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,227.33 | 2020-2025 | |
| Smith+Nephew, INC. | $844.95 | 2020-2025 | Collagenase Santyl, Pico, Renasys Go V2 Home |
| Organogenesis INC. | $510.41 | 2020-2024 | Puraply |
| Paratek Pharmaceuticals, INC. | $392.43 | 2022-2025 | Nuzyra |
| Kci USA, INC. | $95.99 | 2021-2023 | Activ.A.C., Promogran Prisma |
| Mimedx Group, INC. | $76.05 | 2025 | |
| Hartmann USA, INC. | $61.66 | 2022-2025 | Zetuvit Plus 10x10 P10 |
| Reapplix INC. | $40.03 | 2020 | |
| Tactile Systems Technology INC | $33.41 | 2020 | |
| Solventum Corporation | $23.10 | 2025 | 3m Cavilon, Activ.A.C. |
| Cgg Medical INC | $20.57 | 2023 | |
| Molnlycke Health Care US, LLC | $20.06 | 2023 | Exufiber Ag+, Mesalt, Mepilex Border Flex |
| Reprise Biomedical, INC. | $17.83 | 2025 | Miro3d |
| Kerecis Limited | $11.21 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dorsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.